Patents by Inventor Craig Leonard Heatley

Craig Leonard Heatley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8586064
    Abstract: The treatment of humans or other mammals for eczema and/or psoriasis using dosage forms or compositions that include cetyl myristate alone or (in admixture or serially) both cetyl myristate and cetyl palmitate.
    Type: Grant
    Filed: January 29, 2013
    Date of Patent: November 19, 2013
    Assignee: Lypanosys Pte Limited
    Inventors: Timothy David Meakin, Dianne Cadwallader, Craig Leonard Heatley
  • Patent number: 8535696
    Abstract: The treatment of humans or other mammals for eczema and/or psoriasis using dosage forms or compositions that include cetyl myristate alone or (in admixture or serially) both cetyl myristate and cetyl palmitate.
    Type: Grant
    Filed: February 24, 2012
    Date of Patent: September 17, 2013
    Assignee: Lypanosys Pte Limited
    Inventors: Timothy David Meakin, Dianne Cadwallader, Craig Leonard Heatley
  • Publication number: 20130237600
    Abstract: The treatment of humans or other mammals for eczema and/or psoriasis using dosage forms or compositions that include cetyl myristate alone or (in admixture or serially) both cetyl myristate and cetyl palmitate.
    Type: Application
    Filed: January 29, 2013
    Publication date: September 12, 2013
    Applicant: Lypanosys Pte Limited
    Inventors: Timothy David MEAKIN, Dianne CADWALLADER, Craig Leonard HEATLEY
  • Patent number: 6696491
    Abstract: A treatment for humans or other mammals for irritable bowel syndrome (IBS) or irritable bowel disease (IBD) is disclosed using dosage forms or compositions that comprise cetyl myristate alone or (in admixture or serially) both cetyl myristate and cetyl palmitate.
    Type: Grant
    Filed: March 27, 2003
    Date of Patent: February 24, 2004
    Assignee: Meracol Corporation Limited
    Inventors: Timothy David Meakin, Dianne Cadwallader, Craig Leonard Heatley
  • Publication number: 20030171432
    Abstract: The treatment of humans or other mammals for irritable bowel syndrome (IBS) or irritable bowel disease (IBD) using dosage forms or compositions that include cetyl myristate alone or (in admixture or serially) both cetyl myristate and cetyl palmitate.
    Type: Application
    Filed: March 27, 2003
    Publication date: September 11, 2003
    Inventors: Timothy David Meakin, Dianne Cadwallader, Craig Leonard Heatley